Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

Universitas Airlangga

ClinicalTrials.gov lists Universitas Airlangga as lead sponsor of 21 trials. It has 4 active development programs and 2 approved assets.

ID Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

10 0 2018 2027

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 4 registered with a 2026 start date. The hollow diamonds on the dashed line are a forecast of the full-year count, planned starts included: about 4 in 2026 and about 4 in 2027, the average of the 24 months through September, counted as registered and carried forward. The columns, the lighter one included, count trials registered so far with a start date in the year, planned starts included; the forecast looks ahead to the count for the whole year, so it is not the same measure. This method has not been backtested on organizations. In backtests on conditions with as many trial starts a year as this organization (5 to 20), forecasts made part-way through the year were typically off by about 28 percent and ran about 20 percent low against the count later registered; forecasts made before the year began were off by about 39 percent and ran about 37 percent low against the count later registered. These figures rest on a few years of history (target years from 2018 to 2025, varying by figure), place each condition as it is mapped today rather than as it was then, and score against a count for the newest year that was still being revised. Only condition series were scored. The 2026 forecast is below the 4 already registered with a 2026 start date: at the cutoff, 1 trials were already registered to start in October to December, more than the method's monthly average allows for, and the method does not use those planned starts.

Logo Universitas Airlangga, Surabaya, via Wikimedia Commons, CC BY-SA 4.0. Shown to identify the organization; it may be a registered trademark.

This page covers Universitas Airlangga: 21 lead-sponsored trials and 0 legal-entity registrations.

Get the Universitas Airlangga report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (42)

Shown in this order: most trials first.

Disease areas
Disease area Trials
COVID-19 9
Obesity 6
Dementia 4
Failure to Thrive 3
Hypertension 3

Trials by start year as sponsor or collaborator (9)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 4
2025 3
2024 4
2023 10
2022 10
2021 4
2020 2
2019 1
2018 2

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (4)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Neoadjuvant Chemotherapy Breast Neoplasms Not reported 1
Nigella sativa toothpaste Gingivitis Not reported 1
The Control group Dementia Not reported 1
Standard diet Hypertension Not reported 1

Approved assets (2)

Shown in this order: max phase first.

Approved assets
Drug Trials
D'Oxyva 1
PRAVASTATIN SODIUM 1

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
83% hit target (n=6) 86% on time (n=7)

Journals published in (107)

Shown in this order: most published in first.

Journals published in
Journal Publications
The New England journal of medicine 6
Hypertension (Dallas, Tex. : 1979) 5
Lancet (London, England) 4
Australasian journal on ageing 3
BMJ (Clinical research ed.) 3

Organization relationships (19)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Dhaka Medical College Co sponsors trial with 1
Prince of Songkla University in Southern Thailand, Thailand Co sponsors trial with 1
Oxford University Clinical Research Unit, Vietnam Co sponsors trial with 1
Hospital Queen Elizabeth, Malaysia Co sponsors trial with 1
University of Oxford Co sponsors trial with 1

Latest dated events (40)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-04-28 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-03-30 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-12-19 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (20)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
CD4 Trial collaborator Named in trial inclusion criteria
INA Trial collaborator Named in trial inclusion criteria
ADIPOQ Trial sponsor Biospecimen collected in a trial
ATP12A Trial collaborator Named in trial exclusion criteria
ATP4A Trial collaborator Named in trial exclusion criteria

Biomarkers this organization publishes on (53)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
IL6 4
TGFB1 3
TNF 3
IL10 2
IL17A 2

On Scientist.com

Universitas Airlangga is listed as a research supplier in the Scientist.com network.

Website
www.unair.ac.id

Source: Scientist.com supplier network

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.

Work with Universitas Airlangga on Scientist.com

For prices, more details, or to contact Universitas Airlangga, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.